ANI Pharmaceuticals Inc. Registered Shares DL-,0001
- BID
68
- ASK
68.5
- 995 Units259 Units
- 07/21, 20:11:28 PM
Sector and Industry
Healthcare, Biopharmaceuticals
Performance (1Y)
23.21%
Market Cap
-
P/E Ratio
23.75
Dividend Yield
0.00 %
Earnings per Share
2.95 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| Eli Lilly and Company | 864.54 Bil. | 57.78 Bil. | 46.82 | +86.88 % | 0.00 | - |
| Johnson & Johnson | 425.70 Bil. | 83.48 Bil. | 18.82 | +82.71 % | 0.00 | - |
| AbbVie Inc. | 343.94 Bil. | 54.21 Bil. | 96.78 | -5.29 % | 0.00 | - |
| Roche Holding AG | 286.62 Bil. | 65.80 Bil. | 20.72 | +58.45 % | 0.00 | - |
| AstraZeneca PLC | 244.91 Bil. | 52.09 Bil. | 27.55 | +39.41 % | 0.00 | - |
| NOVARTIS AG | 224.76 Bil. | 48.44 Bil. | 18.30 | +12.45 % | 0.00 | - |
| Merck & Co. Inc. | 221.79 Bil. | 57.55 Bil. | 14.46 | +2.25 % | 0.00 | - |
| Novo-Nordisk AS B | 193.52 Bil. | 41.49 Bil. | 14.11 | +1.54 % | 0.00 | - |
| Amgen Inc. | 150.16 Bil. | 32.57 Bil. | 23.01 | +80.77 % | 0.00 | - |
| Gilead Sciences Inc. | 129.70 Bil. | 26.10 Bil. | 18.10 | +1,599.93 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 68 G | 0 Units |
| PRICE DETERMINATION TIME | 07/21/2026 / 08:01:36 PM | |
| DAILY VOLUME (UNITS) | 0 | |
| DAILY HIGH / LOW | 68.5 | 67.5 |
| PREV. DAY'S PRICE | 68 | (07/20) |
| CHANGE DAY BEFORE | +0.00 | 0.00 % |
| 52 WEEK HIGH / LOW | 84 (10/27) | 54.5 (07/30) |
Key Figures (in EUR)
| 2023 | 2024 | 2025 | 2026e | 2027e | |
|---|---|---|---|---|---|
EARNINGS PER SHARE | 0.87 | -0.96 | 2.95 | 8.27 | 9.35 |
DIVIDENDS PER SHARE | 0.00 | 0.00 | 0.00 | - | - |
DIVIDEND YIELD IN % | 0.00 % | 0.00 % | 0.00 % | - | - |
DIVIDEND GROWTH IN % | - | - | - | - | - |
PRICE - EARNINGS RATIO | 58.49 | - | 23.75 | 8.37 | 7.40 |
PRICE - BOOK RATIO | 2.61 | 2.89 | 3.29 | - | - |
PRICE - SALES RATIO | 2.06 | 1.74 | 1.90 | - | - |
PRICE - CASH FLOW RATIO | 8.43 | 16.68 | 9.05 | - | - |
Master Data
| WKN | A1W15D |
| ISIN | US00182C1036 |
| SYMBOL | BSFA |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | ANI PHARMACEUT. DL-,0001 |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | - |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Biopharmaceuticals |
| NUMBER OF SHARES | - |
| MARKET CAPITALISATION | - |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | -4.17 % | -1.43 % | 0.73 % | -4.83 % | 23.21 % | 54.71 % | 159.40 % | 1.47 % |
| HIGH | 72.00 | 75.50 | 76.50 | 76.50 | 84.00 | 84.00 | 84.00 | 76.50 |
| LOW | 68.50 | 68.00 | 63.00 | 61.00 | 54.50 | 44.20 | 21.60 | 61.00 |
Dividende
pro Aktie
ANI PHARMACEUT. DL-,0001 does not deliver dividend information
Company profile
ANI Pharmaceuticals, Inc. is a bio-pharmaceutical company, which engages in the development, manufacture, and marketing of branded and generic prescription pharmaceuticals. It operates through the Generics, Established Brands, and Other, and Rare Disease segments. The Generics, Established Brands, and Other segment consists of contract manufactured products, development services, royalties, and other. The Rare Disease segment involves the operations related to Cortrophin Gel. The company was founded on August 29, 1996 and is headquartered in Baudette, MN.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.